The global research antibodies market (including reagents) is projected to reach USD 12.60 Billion by 2022 from USD 9.33 Billion in 2017, growing at a CAGR of 6.2% during the forecast period. Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and growing collaboration between industries and academic institutes are the key drivers of the market.
The report analyzes the global research antibodies market (including reagents) by product, technology, application, end user, and region. Based on product, the market is segmented into reagents and antibodies. The reagents segment accounted for the major share of the research antibodies market (including reagents) in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques. Furthermore, based on type, the reagents market has been further segmented into media & sera, stains & dyes, fixatives, buffers, probes, solvents, enzymes, and others (controls, stabilizers, and diluents). The media & sera segment is expected to dominate the market in 2016 due to its high usage in all types of assays, culture procedures, and techniques.

The antibodies market has also been segmented on the basis of type, source, and research area. Based on type, the research antibodies market is segmented into primary antibodies and secondary antibodies. In 2016, the primary antibodies is expected to dominate the market due to its high adoption in numerous types of assay formats, including western blotting, ELISA, immunoprecipitation, and IHC. These antibodies provide high specificity, sensitivity, and affinity; which further drives their high adoption. On the basis of source, the antibodies market has been segmented into mice, rabbit, and other animals (chickens, goats, rats, guinea pigs, hamsters, and sheep). The mice segment dominated the market in 2016. Based on research area, the antibodies market has been segmented into oncology, infectious diseases, immunology, neurobiology, stem cell, and others (epigenetics, toxicology, and cardiovascular diseases). The oncology segmented held the largest share of the market in 2016 due to the fact that cancer is the leading cause of deaths worldwide, which has driven the focus on its early detection and treatment. Moreover, understanding the cause and risk factors of cancer also form an important area of cancer research.

Based on technology, the research antibodies market is segmented into western blotting, flow cytometry, ELISA, immunohistochemistry, immunofluorescence, immunoprecipitation, and others (electrophoresis, bio-imaging, and microarrays). The western blotting segment accounted for the largest share of the global research antibodies market in 2016. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.

On the basis of application, the research antibodies market is segmented into proteomics, drug development, and genomics. In 2016, the proteomics segment dominated the applications market. This large share can be attributed to the high deployment of proteomic-based approaches in disease profiling, increasing government funding, rising demand of personalized & protein therapeutics, and increasing R&D expenditure.

Based on end user, the market has been segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. In 2016, the pharmaceutical and biotechnological companies accounted for the largest share of the research antibodies market. This can be attributed to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the proteomics research sector.

Geographically, the global research antibodies market is segmented into Europe, Asia-Pacific, North America, Latin America, and the Middle East & Africa. North America holds the largest share of this market. However, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the growing proteomics and genomics research & increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.

The global research antibodies and reagent market is characterized by a large number of players. The market is highly competitive in nature and is dominated by Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.). Key players in the market are pursuing several organic and inorganic growth strategies such as product launches, expansions, acquisitions, and agreements to garner larger shares of the market. During 2013 to 2017, companies adopted product launches as their major growth strategy followed by acquisitions.

免疫蛍光測定アッセイの世界市場予測（～2023年）：試薬、一次抗体、二次抗体、キット、画像装置、顕微鏡BT-6044 / MarketsandMarkets / 2018年2月28日 / MarketsandMarketsが発行した当調査レポートでは、免疫蛍光測定アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、種類別分析、疾患別分析、需要先別分析、免疫蛍光測定アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunofluorescence assay market is projected to reach USD 2.01 Billion by 2023 from USD 1.51 Billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market. The report analyzes the global immunofluorescence assay market by product, type, disease, end user, and region. On the basis of product, the reagents segment accounted for the largest share of the global immunofluorescence assay market in 2017. The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields,...

コンパニオン診断（CDx）の世界市場予測（～2022年）MAM-MD5463 / MarketsandMarkets / 2017年8月1日 / 当調査レポートでは、コンパニオン診断（CDx）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別分析、疾患別分析、需要先別分析、地域別分析、コンパニオン診断（CDx）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global market is projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. The report analyzes the companion diagnostics market by product & service, technology, indication, end user, and region. On the basis of product & service, the assay kits & reagents segment accounted for the largest share in 2016, owing to...

コンピテントセル（形質転換受容性細胞）の世界市場予測（～2022年）MAM-BT5430 / MarketsandMarkets / 2017年7月19日 / 当調査レポートでは、コンピテントセル（形質転換受容性細胞）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、用途別分析、需要先別分析、地域別分析、コンピテントセル（形質転換受容性細胞）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Competent cells are E.coli cells that possess altered cell walls which enable the assimilation of foreign DNA. These cells are widely used in cloning and protein expressions applications. The global competent cells market is projected to reach USD 2.22 Billion by 2022 from USD 1.37 Billion in 2017, at a CAGR of 10.2%. The advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are the major driving factors for this market. The competent cells market is segmented on the basis of type, application, and end...

タンパク質アッセイの世界市場予測（～2022年）MAM-BT5289 / MarketsandMarkets / 2017年5月24日 / 当調査レポートでは、タンパク質アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、種類別分析、用途別分析、技術別分析、タンパク質アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1%. The increasing pharmaceutical & biotech R&D expenditure and the favorable government funding scenario for proteomics research are the major factors that are expected to drive the growth of the market during the forecast period. The global protein assays market is segmented based on type, product, technology, application, end user, and region. The market, on the basis of type, is segmented into dye-binding assays, copper-ion based assays, test strip-based assays, and other protein assays. In 2017, the...

マイコプラズマ検査の世界市場予測（～2022年）：検査キット、試薬、装置、技術、用途、需要先MAM-BT3371 / MarketsandMarkets / 2017年6月14日 / 当調査レポートでは、マイコプラズマ検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス別分析、技術別分析、用途別分析、需要先別分析、マイコプラズマ検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global mycoplasma testing market is expected to reach USD 943.4 Million by 2022 from USD 523.3 Million in 2017, at a CAGR of 12.5%. The increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination are expected to drive the growth of this market. The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments. The kits & reagent segment is expected to lead the global market in 2017. The frequent purchase...

セルラー集団検診（健診）の世界市場予測（～2022年）MAM-BT5413 / MarketsandMarkets / 2017年7月14日 / 当調査レポートでは、セルラー集団検診（健診）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、サンプル別分析、健診場所別分析、地域別分析、セルラー集団検診（健診）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cellular health screening market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period. A number of factors such as increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are driving the demand for global cellular health screening. On the...

NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場予測（～2022年）MAM-BT5297 / MarketsandMarkets / 2017年5月26日 / 当調査レポートでは、NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品・サービス別分析、技術別分析、需要先別分析、地域別分析、NGS（次世代シーケンサー）ベースRNAシーケンスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global NGS-based RNA-seq market is projected to reach USD 2.65 Billion by 2022 from USD 1.05 Billion in 2017, at a CAGR of 20.2% during the forecast period. The advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-Seq grants, increasing number of research activities, and rapid growth in precision medicine are the key factors driving the growth of the market. On the other hand, lack of skilled professionals and standardization concerns of RNA-seq in diagnostic testing are some of the key factors limiting the growth of the market. The increasing applications of RNA-seq...

デジタルPCR及びリアルタイムPCR（qPCR）の世界市場予測（～2022年）：装置、試薬MAM-BT3161 / MarketsandMarkets / 2017年6月27日 / 当調査レポートでは、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、需要先別分析、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global dPCR and qPCR market is expected to reach USD 5.31 Billion by 2022, growing at a CAGR of 8.9% during 2017-2022. Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR market. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market. In addition to this, adoption and implementation of...

タンパク発現の世界市場予測（～2022年）：大腸菌、哺乳類、イースト、ピキア属、昆虫、バキュロウイルス、無細胞MAM-BT2435 / MarketsandMarkets / 2017年7月4日 / 当調査レポートでは、タンパク発現の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、製品別分析、用途別分析、地域別分析、タンパク発現の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Protein expression is a technique or methodology in which proteins are characterized, modified, and synthesized in the host cells. The selected protein is typically achieved by the modification or alteration of the protein expression process in a living cell. Various kinds of protein expression systems are used for the production of a broad range of therapeutic proteins such as insulin, interferons, and interleukins. The global market is expected to reach USD 2.850.5 Million by 2022 from USD 1,654.0 Million in 2017, at a CAGR of 11.5% during the forecast period. The rising prevalence of chronic disorders disease, the growing number...

家禽診断の世界市場予測（～2022年）MAM-MD5241 / MarketsandMarkets / 2017年5月9日 / 当調査レポートでは、家禽診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、検査種類別分析、疾患種類別分析、サービス別分析、地域別分析、家禽診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global poultry diagnostics market is projected to reach USD 495.3 Million by 2022 from USD 300.6 Million in 2017, growing at a CAGR of 10.5%. Significant increase in the avian diseases outbreak and rising incidence of zoonotic diseases, rising consumer focus on food safety along with the increasing animal health awareness, and increasing trade in terms of export within the poultry industry are the major drivers for the growth of the global market for poultry diagnostics. Other factors such as rising demand for poultry-derived food products across geographies and the increasing animal healthcare expenditure in emerging countries are also...